Wikisage, the free encyclopedia of the second generation, is digital heritage

Perampanel: Difference between revisions

From Wikisage
Jump to navigation Jump to search
No edit summary
(refs)
 
Line 21: Line 21:


{{wikidata|Q868658}}
{{wikidata|Q868658}}
<references/>
 
{{refs}}


[[Category:Anticonvulsant]]
[[Category:Anticonvulsant]]

Latest revision as of 01:31, 7 May 2019

(Fycompa) is an AED [1] 5′-(2-Cyanphenyl)-1′-phenyl-2,3′-bipyridinyl-6′(1′H)-on [2] Perampanel was efficacious and well tolerated, despite the observation that the patient population exhibited characteristics of highly refractory epilepsy

[3]

ATC

perampanel
[4]


Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies


Q868658 at Wikidata  Interwiki via Wikidata


References

References:
  1. ↑ Perampanel: A Review in Drug-Resistant Epilepsy
  2. ↑ http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-_Product_Information/human/002434/WC500130815.pdf
  3. ↑ http://n.neurology.org/content/suppl/2016/04/10/WNL.0000000000001930.DC3/french_950.pdf
  4. ↑ N03AX22
Retrieved from "https://en.wikisage.org/w/index.php?title=Perampanel&oldid=8280"